Session Information
-
WCLC 2017
18th World Conference on Lung Cancer
Conference Program for the 18th World Conference on Lung Cancer in Yokohama, Japan
Download PDF of the Conference Program: Click Here.
Onsite Conference Program Addendum (17/10/2017): Click Here.
Download PDF of the Abstract Book: Click Here.
Financial Disclosure Summary (PDF): Click Here.Presentation Date(s):- Oct 15 - 18, 2017
- Total Presentations: 2295
October 14 Sat
Oct 14 Sunday
October 15 Sun
Oct 15 Monday
October 16 Mon
Oct 16 Tuesday
October 17 Tue
Oct 17 Wednesday
October 18 Wed
Oct 18
-
+
P1.03 - Chemotherapy/Targeted Therapy
- 09:30 - 16:00
- 10/16/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Chemotherapy/Targeted Therapy
-
+
P1.03-005 - Phase 2 Study of Ceritinib in Patients with ALK+ NSCLC with Prior Alectinib Treatment in Japan: ASCEND-9
09:30 - 09:30 | Presenter: Hidehito Horinouchi | Author(s): M. Maemondo, T. Hida, M. Takeda, K. Hotta, F. Hirai, Y.H. Kim, S. Matsumoto, Tetsuya Mitsudomi, Takashi Seto, S. Moizumi, K. Tokushige, B. Hatano, Makoto Nishio
- Abstract
Loading...
-
+
MA 05 - Immuno-Oncology: Novel Biomarker Candidates
- 15:45 - 17:30
- 10/16/2017
- Location: Room 303 + 304
- Type: Mini Oral
- Track: Immunology and Immunotherapy
- Moderators:Yoichi Nakanishi, P. Mitchell
-
+
MA 05.04 - Distinct Immunosuppressive Microenvironment Determines Poor Prognosis of Nonsmokers with Adenocarcinoma of Non-Small Cell Lung Cancer
16:00 - 16:05 | Presenter: Tomonari Kinoshita | Author(s): T. Fujita, Y. Hayashi, Takashi Ohtsuka, Tetsuya Mitsudomi, Hisao Asamura, Kazuhiro Yasufuku, Y. Kawakami
- Abstract
Loading...
-
+
OA 07 - Biomarker for Lung Cancer
- 15:45 - 17:30
- 10/16/2017
- Location: Room 503
- Type: Oral
- Track: Biology/Pathology
- Moderators:Philip Christopher Mack, Shinichi Toyooka
-
+
OA 07.06 - Innate Genetic Evolution of Lung Cancers and Spatial Heterogeneity: Analysis of Treatment-Naïve Lesions
16:50 - 17:00 | Presenter: Kenichi Suda | Author(s): J. Kim, I. Murakami, L. Rozeboom, C.J. Rivard, Tetsuya Mitsudomi, A. Tan, Fred R. Hirsch
- Abstract
Loading...
-
+
MA 12 - Circumventing EGFR Resistance
- 11:00 - 12:30
- 10/17/2017
- Location: F205 + F206 (Annex Hall)
- Type: Mini Oral
- Track: Advanced NSCLC
- Moderators:Wan Ling Tan, Nobuyuki Yamamoto
-
+
MA 12.07 - Adjusted Indirect Comparison of Osimertinib to Chemotherapy in NSCLC Patients with EGFRm T790M Who Progressed after EGFR-TKI
11:40 - 11:45 | Presenter: Christopher Hoyle | Author(s): F. Andersohn, Tetsuya Mitsudomi, Tony SK Mok, James Chih-Hsin Yang, M. Green, H. Mann
- Abstract
Loading...
-
+
P3.02 - Biology/Pathology
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Biology/Pathology
-
+
P3.02-059 - T790M and C797S as Mechanisms of Acquired Resistance to Dacomitinib in Cell Models
09:30 - 09:30 | Presenter: Yoshihisa Kobayashi | Author(s): T. Fujino, M. Nishino, S. Ohara, Y. Sesumi, M. Chiba, M. Shimoji, K. Tomizawa, T. Takemoto, Tetsuya Mitsudomi
- Abstract
Loading...
-
+
P3.16 - Surgery
- 09:30 - 16:00
- 10/18/2017
- Location: Exhibit Hall (Hall B + C)
- Type: Poster Session with Presenters Present
- Track: Surgery
-
+
P3.16-049 - Surgery with Continued TKI Therapy After Acquiring Resistance to EGFR or ALK TKI
09:30 - 09:30 | Presenter: Shuta Ohara | Author(s): Yoshihisa Kobayashi, T. Fujino, Y. Sesumi, M. Nishino, M. Chiba, M. Shimoji, K. Tomizawa, T. Takemoto, Tetsuya Mitsudomi
- Abstract
Loading...
-
+
ES 08 - Molecular Diagnostics and Targeted Therapy
- 11:00 - 12:30
- 10/18/2017
- Location: Main Hall
- Type: Educational Session
- Track: Chemotherapy/Targeted Therapy
- Moderators:Kwun M Fong, David Planchard
-
+
ES 08.01 - Overview of Diagnostics and Pathology
11:00 - 11:15 | Presenter: Tetsuya Mitsudomi
- Abstract
Loading...